Uma Krishnamurti, MD, MBBS, PhD
Professor of Pathology and Director of Breast PathologyCards
About
Titles
Professor of Pathology and Director of Breast Pathology
Director of Breast Pathology, Pathology
Biography
Dr. Krishnamurti is a pathologist with expertise in breast pathology, cytopathology, and gynecologic pathology. She completed her residency training in Anatomic and Clinical Pathology at the University of Minnesota and the University of Pittsburgh followed by a Fellowship in Cytopathology at the University of Pittsburgh. She joined the faculty at Yale in 2021, where she is currently Professor of Pathology and Director of Breast Pathology. She has been the primary author of the College of American Pathologists (CAP) gynecologic cancer reporting synoptic templates. She served as Principal Investigator and Director of the Breast Satellite Tissue Bank of Winship Cancer Institute, Emory University, from 2015 to 2021. Her main areas of academic interest include diagnostic, prognostic, and predictive markers of triple-negative and HER2-positive breast cancer.
Dr. Krishnamurti has been a course faculty at the American Society of Cytopathology (ASC), American Society for Clinical Pathology (ASCP), and College of American Pathologists (CAP) annual meetings. She has Chaired the Research and Current Concepts Committee of the ASC and served as a member of the American Joint Commission on Cancer Expert Panel on Protocol for Cancer Staging of the Vulva. Currently, Dr. Krishnamurti serves on the Breast section of the Cancer Committee of the CAP, and on the ASC Bulletin and Cytopath Podcast Committee.
Appointments
Pathology
ProfessorPrimary
Other Departments & Organizations
- Breast Pathology
- Pathology
- Surgical Pathology
- Yale Medicine
- Yale New Haven Health System
Education & Training
- Fellowship
- University of Pittsburgh (2004)
- Residency
- University of Pittsburgh (2003)
- PhD
- University of Minnesota (1999)
- MD
- University of Delhi (1990)
- MBBS
- University of Delhi (1985)
- MD
- University of Delhi (1984)
Board Certifications
Anatomic & Clinical Pathology
- Certification Organization
- AB of Pathology
- Original Certification Date
- 2003
Research
Publications
2026
Lessons Learned From 26 Adenomyoepitheliomas of the Breast.
Colón Cartagena L, Perera N, Liang Y, Zhan H, Krishnamurti U. Lessons Learned From 26 Adenomyoepitheliomas of the Breast. The American Journal Of Surgical Pathology 2026 PMID: 42676113, DOI: 10.1097/pas.0000000000002598.Peer-Reviewed Original ResearchThe new (version 9) American Joint Committee on Cancer (AJCC) tumor‐node‐metastasis (TNM) staging protocol for carcinoma of the vulva
Olawaiye A, Asare E, Hagemann I, Bhosale P, Gaillard S, Rous B, Rungruang B, Uppal S, Turashvili G, Alektiar K, Cosin J, Krishnamurti U, Chen L, Fujiwara K, Powell M, Cuello M, Mutch D. The new (version 9) American Joint Committee on Cancer (AJCC) tumor‐node‐metastasis (TNM) staging protocol for carcinoma of the vulva. CA A Cancer Journal For Clinicians 2026, 76: e70104. PMID: 42665926, PMCID: PMC13525161, DOI: 10.3322/caac.70104.Peer-Reviewed Original ResearchBeyond a single disease: review of rare histological subtypes of triple-negative breast cancer with implications for prognosis and treatment
Bonadio R, Barroso-Sousa R, Miranda D, Pessoa B, Rathi K, Kahila M, Krishnamurti U, Lustberg M, Kahn A. Beyond a single disease: review of rare histological subtypes of triple-negative breast cancer with implications for prognosis and treatment. Npj Breast Cancer 2026 DOI: 10.1038/s41523-026-01018-8.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsPathologic Characterization of Non-Mass Enhancement Lesions of the Breast in MRI-guided Biopsy
Jordan T, Liang Y, Colón Cartagena L, Buza N, Krishnamurti U, Zhan H. Pathologic Characterization of Non-Mass Enhancement Lesions of the Breast in MRI-guided Biopsy. Human Pathology 2026, 106220. PMID: 42556743, DOI: 10.1016/j.humpath.2026.106220.Peer-Reviewed Original ResearchNavigating Human Epidermal Growth Factor Receptor 2 (HER2) Assessment by Organ Systems: A Guidebook to HER2 Testing in Solid Tumors.
Turashvili G, Allison K, Baskovich B, Deftereos G, Fanburg-Smith J, Hulkower K, Krishnamurti U, Miller D, Ramineni M, Rosa M, Seethala R, Sundling K, Wei S, Harik L. Navigating Human Epidermal Growth Factor Receptor 2 (HER2) Assessment by Organ Systems: A Guidebook to HER2 Testing in Solid Tumors. Archives Of Pathology & Laboratory Medicine 2026 PMID: 42320885, DOI: 10.5858/arpa.2025-0593-cp.Peer-Reviewed Original ResearchHistomorphologic analysis and clinical correlation of atypical apocrine lesions in breast pathology
Podany P, Zhan H, Colón-Cartagena L, Ai D, Du J, Krishnamurti U, Liang Y. Histomorphologic analysis and clinical correlation of atypical apocrine lesions in breast pathology. Human Pathology 2026, 175: 106158. PMID: 42176994, DOI: 10.1016/j.humpath.2026.106158.Peer-Reviewed Original ResearchDiagnosis of Ductal Carcinoma in Situ in Breast Biopsies for a Radiological Mass Lesion: Did We Miss Something?
Theriot J, Zhan H, Colón-Cartagena L, Lotfi P, Krishnamurti U, Liang Y. Diagnosis of Ductal Carcinoma in Situ in Breast Biopsies for a Radiological Mass Lesion: Did We Miss Something? International Journal Of Surgical Pathology 2026, 34: 1446-1451. PMID: 41944434, DOI: 10.1177/10668969261436010.Peer-Reviewed Original ResearchQuantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score
He M, Chan N, Liu M, Robbins C, Bates K, Benanto J, Colón-Cartagena L, Kahila M, Zhan H, Krishnamurti U, Moutafi M, Yaghoobi V, Liebler D, Fulton R, Rimm D. Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score. Applied Immunohistochemistry & Molecular Morphology 2026, 34: 143-154. PMID: 41709478, PMCID: PMC13143368, DOI: 10.1097/pai.0000000000001311.Peer-Reviewed Original Research
2025
Prognostic significance of pelvic washing cytology in early stage endometrial cancer: A 10‐year matched cohort analysis from a large single institute
Wang M, Abi‐Raad R, Adeniran A, Krishnamurti U, Buza N, Hui P, Cai G, Sun T. Prognostic significance of pelvic washing cytology in early stage endometrial cancer: A 10‐year matched cohort analysis from a large single institute. Cancer Cytopathology 2025, 133: e70057. PMID: 41159755, DOI: 10.1002/cncy.70057.Peer-Reviewed Original ResearchInvasive breast carcinoma in a patient with PHTS: a case report
Zhan H, Fischbach N, Lynch M, Liang Y, Krishnamurti U, Cohen P. Invasive breast carcinoma in a patient with PHTS: a case report. Diagnostic Pathology 2025, 20: 120. PMID: 41107919, PMCID: PMC12532417, DOI: 10.1186/s13000-025-01715-1.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
News
News
- September 24, 2026
Study Informs How to Diagnose Underrecognized Breast Tumor
- June 08, 2026
Pathology, Laboratory Medicine Honor Residents, Fellows in Graduation Ceremony
- March 17, 2026
Yale Pathology Will Have Strong Presence at USCAP 2026
- June 12, 2025
Pathology, Laboratory Medicine Residents, Fellows Feted at Graduation Ceremony